Epilepsy & SUDEP Risk Monitoring Platform
Monitoring for convulsive seizures and cardiorespiratory dysfunction in drug-resistant epilepsy
Development/TestingActive
Key Facts
Indication
Monitoring for convulsive seizures and cardiorespiratory dysfunction in drug-resistant epilepsy
Phase
Development/Testing
Status
Active
Company
About Neurava
Neurava is a private, pre-revenue medical device startup developing a first-of-its-kind wearable monitoring system for drug-resistant epilepsy. Its core innovation is a dual-device platform that not only detects convulsive seizures but also continuously tracks cardiac, respiratory, and oxygenation signals to assess the broader risk of SUDEP, a fatal complication. Backed by over $2M in funding and strategic support from pharmaceutical leader UCB, the company is advancing its technology through user testing with the goal of enabling data-driven, at-home care management and life-saving interventions.
View full company profile